identified neoantigen‐specific lymphocytes in the peripheral blood of melanoma patients and demonstrated that circulating CD8+ PD‐1+ lymphocytes closely resemble the tumor‐resident anti‐tumor lymphocyte population.[130] Similarly, Siddiqui et al. The gene discussed is CD8A; the disease is melanoma.